Abstract
Computational chemical methods have been used to correlate the molecular properties of the 10 ACE inhibitors (captopril, enalapril, perindopril, lisinopril, ramipril, trandolapril, quinapril, fosinopril, benazepril, and cilazapril) and some of their active metabolites (enalaprilat, perindoprilat, ramiprilat, trandolaprilat, quinaprilat, fosinoprilat, benazeprilat, and cilazaprilat). The computed pK a values correlate well with the available experimental values. In the dicarboxylic ACE inhibitors, the carboxyalkyl carboxylate group of the ACE inhibitors studied is more acidic than the C-terminal carboxylate. However, at physiological pH = 7.4 both carboxyl groups of ACE inhibitors are completely ionized and the dicarboxyl-containing ACE inhibitors behave as strong acids. The available experimental partition coefficients of these ACE inhibitors investigated are well reproduced by the neural network-based ALOGPs and the fragment-based KoWWiN methods. All parent drugs (and prodrugs), with the exception of fosinopril, are compounds with low lipophilicity. Calculated pK a, lipophilicity, solubility, absorption, and polar surface area of the most effective ACE inhibitors for the prevention of myocardial infarction, perindopril and ramipril, were found similar. Therefore, it is probable that the experimentally observed differences in the survival benefits in the first year after acute myocardial infarction in patients 65 years of age or older correlate closely to the physicochemical and pharmacokinetic characteristics of the specific ACE inhibitor that is used.
Similar content being viewed by others
References
Timmermans, P. B. M. W. M. and Smith, R. D., in Burger’s Medicinal Chemistry and Drug Discovery, 5th Edition, Vol. 2 Therapeutic Agents (Wolff, M., Editor), p. 265. Wiley, New York. 1996.
Opie, L. H., Angiotensin Converting Enzyme Inhibitors, 2nd Edition. Wiley—Liss, New York, 1994.
Wong, J., Patel, R. A., and Kowey, P. R., Prog. Cardiovasc. Dis. 47, 116 (2004).
Bertrand, M. E., Curr. Med. Res. Opin. 20, 1559 (2004).
Okrucká, A., Pecháň, J., and Kratochvíl’ová, H., Platelets 9, 63 (1998).
Remková, A. and Kratochvíl’ová, H., Blood Coagul. Fibrinol. 11, 641 (2000).
Salvetti, A., Drugs 40, 800 (1990).
Furberg, C. D., Herrington, D. M., and Psaty, B. M., Lancet 354, 1202 (1999).
Pilote, L., Abrahamowicz, M., Rodrigues, E., Eisenberg, M. J., and Rahme, E., Ann. Intern. Med. 141, 102 (2004).
Brown, N. J. and Vaughan, D. E., Circulation 97, 1411 (1998).
Spyroulias, G. A. and Cordopatis, P., Curr. Enzym. Inhibition 1, 29 (2005).
Hilal, S. H., El-Shabrawy, Carreira, L. A., Karickhoff, S. W., Toubar, S. S., and Rizk, M., Talanta 43, 607 (1996).
Hilal, S. H., Karickhoff, S. W., and Carreira, L. A., Quant. Struct.-Act. Relat. 14, 348 (1995).
Carreira, L.A., Hilal, S. H, and Karickhoff, S. W., in Theoretical and Computational Chemistry, Quantitative Treatment of Solute/Solvent Interactions, chapter 9 (Politzer, P. and Murray, J. S., Editors). Elsevier, Amsterdam, 1994.
Hilal, S. H., Karickhoff, S. W., and Carreira, L. A., QSAR Comb. Sci. 22, 565 (2003).
Tetko, I. V., Gasteiger, J., Todeschini, R., Mauri, A., Livingstone, D., Ertl, P., Palyulin, V. A., Radchenko, E. V., Zefirov, N. S., Makarenko, A. S., Tanchuk, V. Y., and Prokopenko, V. V., J. Comput.-Aided Mol. Des. 19, 453 (2005).
Tetko, I. V., Drug Discov. Today 10, 1497 (2005).
Tetko, I. V., Bruneau, P., Mewes, H.-W., Rohrer, D. C., and Poda, G. I., Drug Discov. Today 11, 700 (2006).
Ertl, P. and Selzer, P., in Handbook of Chemoinformatics: From Data to Knowledge (Gasteiger, J., Editor), p. 1336. Wiley-VCH, Weinheim, 2003.
Smieško, M. and Remko, M., Chem. Pap. 58, 71 (2004).
Šramko, M., Remko, M., and Garaj, V., Struct. Chem. 16, 391 (2005).
Andújar-Sánches, M., Cámara-Artigas, A., and Jara-Pérez, V., Biophys. Chem. 111, 183 (2004).
Hillaert, S. and Van den Bossche, W., J. Chromatogr., A 895, 33 (2000).
Ozoemena, K. I., Raluca-Ioana, S., van Staden, J. F., and Aboul-Enein, Y. A., Sens. Actuators, B 105, 425 (2005).
Natesh, R., Schwager, S. L. U., Sturrock, E. D., and Acharya, K. R., Nature 421, 551 (2003).
Natesh, R., Schwager, S. L. U., Evans, H. R., Sturrock, E. D., and Acharya, K. R., Biochemistry 43, 8718 (2004).
Ortiz-Salmerón, E., Barón, C., and García-Fuentes, L., FEBS Lett. 435, 219 (1998).
Remko, M. and Garaj, V., Mol. Phys. 101, 2357 (2003).
Yoshida, F. and Topliss, J. G., J. Med. Chem. 43, 2575 (2000).
Abraham, M. H., Zhao, Y. H., Lee, J., Hersey, A., Luscombe, Ch. N., Reynolds, D. P., Beck, G., Sherborne, B., and Cooper, I., Eur. J. Med. Chem. 37, 595 (2002).
Avdeef, A., Curr. Top. Med. Chem. 1, 277 (2001).
Oprea, T. T., J. Comput.-Aided Mol. Des. 16, 325 (2002).
Norinder, U. and Bergström, A. S., Chem. Med. Chem. 1, 920 (2006).
Tetko, I. V. and Tanchuk, V. Y., J. Chem. Inf. Comput. Sci. 42, 1136 (2002).
Tetko, I. V., Tanchuk, V. Y., and Villa, A. E. P., J. Chem. Inf. Comput. Sci. 41, 1407 (2001).
Tetko, I. V., Tanchuk, V. Y., Kasheva, T. N., and Villa, A. E. P., J. Chem. Inf. Comput. Sci. 41, 1488 (2001).
Balakin, K. V., Savchuk, N. P., and Tetko, I. V., Curr. Med. Chem. 13, 223 (2006).
Meylan, W. M. and Howard, P. H., J. Pharm. Sci. 84, 83 (1995).
Ondetti, M. A., Circulation 77(suppl I), 74 (1988).
Razzetti, R. and Acerbi, D., Am. J. Cardiol. 75, 7F (1995).
VCCLAB, Virtual Computational Chemistry Laboratory, http://www.vcclab.org.
Raasch, W., Dendorfer, A., Ball, B., and Dominiak, P., Jpn. J. Pharmacol. 81, 346 (1999).
Lin, J. H. and Lu, A. Y. H., Pharmacol. Rev. 49, 403 (1997).
Higashimori, K., Gante, J., Holzemann, G., and Inagami, T., Hypertension 17, 270 (1991).
Brown, B. and Hall, A. S., Am. J. Hypertens. 18, 127S (2005).
Sauer, W. H., Baer, J. T., Berlin, J. A., and Kimmel, S. E., Am. J. Cardiol. 94, 1171 (2004).
Tetko, I. V. and Poda, G. I., J. Med. Chem. 47, 5601 (2004).
Lombardo, F., Shalaeva, M. Y., Bissett, B. D., and Chistokhodova, N., in LogP2004, The 3rd Lipophilicity Symposium, ETH: Zurich, Switzerland, 2004, p. L–22.
Hou, T. J., Zhang, W., Xia, K., Qiao, X. B., and Xu, X. J., J. Chem. Inf. Comput. Sci. 44, 1585 (2004).
Raevsky, O. A., Fetisov, V. I., Trepalina, E. P., McFarland, J. W., and Schaper, K. J., Quant. Struct.-Act. Relat. 19, 366 (2000).
Ranadive, S. A., Chen, A. X., and Serajuddin, A. T. M., Pharm. Res. 9, 1480 (1992).
Taskinen, T. and Yliruusi, J., Adv. Drug Delivery Rev. 55, 1163 (2003).
Remko, M. and von der Lieth, C.-W., Bioorg. Med. Chem. 12, 5395 (2004).
Remko, M., Swart, M., and Bickelhaupt, F. M., Bioorg. Med. Chem. 14, 1715 (2006).
Zhao, Y. H., Abraham, M. H., Lee, J., Hersey, A., Luscombe, C. N., Beck, G., Sherborne, B., and Cooper, I., Pharm. Res. 19, 1446 (2002).
Kelly, J. G. and O’Malley, K., Clin. Pharmacokinet. 19, 177 (1990).
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., and Kapple, K. D., J. Med. Chem. 45, 2615 (2002).
Refsgaard, H. H. F., Jensen, B. F., Brockhoff, P. B., Padkjær, S. B., Guldbrandt, M., and Christensen, M. S., J. Med. Chem. 48, 805 (2005).
Muegge, I., Med. Res. Rev. 23, 302 (2003).
Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J., Adv. Drug Delivery Rev. 23, 3 (1997).
Ertl, P., Rohde, B., and Selzer, P., J. Med. Chem. 43, 3714 (2000).
Tzakos, A. G., Naqvi, N., Comporozos, K., Pierattelli, R., Theodorou, V., Husain, A., and Gerothanassis, I. P., Bioorg. Med. Chem. Lett. 16, 5084 (2006).
Pascard, C., Guilhem, J., Vincent, M., Rémond, G., Portevin, B., and Laubie, M., J. Med. Chem. 34, 663 (1991).
Clark, D. E., J. Pharm. Sci. 88, 815 (1999).
Walter, E., Kissel, T., and Amidon, G. L., Adv. Drug Delivery Rev. 20, 33 (1996).
Moore, V. A., Irwin, W. J., Timmins, P., Lambert, P. A., Chong, S., Dando, S. A., and Morrison, R. A., Int. J. Pharm. 210, 29 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Remko, M. Acidity, lipophilicity, solubility, absorption, and polar surface area of some ACE inhibitors. Chem. Pap. 61, 133–141 (2007). https://doi.org/10.2478/s11696-007-0010-y
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.2478/s11696-007-0010-y